July 2015

Ariosa Diagnostics, Inc. v. Sequenom, Inc.: The End of Genetic Diagnostic Method Patents?

By: Andreas Baltatzis and Sandra King  |   July 16, 2015

Last month, in Ariosa Diagnostics, Inc. v. Sequenom, the Court of Appeals for the Federal Circuit found U.S. Patent No. 6,258,540 (“the ’540 patent”) invalid as not being directed to patent eligible subject matter under 35 U.S.C. § 101. --- F/3d ---, 2015 WL 3634649, at *1 (C.A.Fed. (Cal.) 2015).